Analyst Ratings Updates (USA)
Applied Aerospace & Defense (AADX) — Guggenheim lowered its price target from $30.00 to $15.00 and maintained a Buy rating.
Applied Aerospace & Defense (AADX) — Citigroup reiterated a Buy rating.
Aardvark Therapeutics (AARD) — Raymond James Financial reiterated a Market Perform rating.
Asbury Automotive Group (ABG) — Stephens downgraded its rating from Overweight to Equal Weight and has a price target of $200.00.
ACADIA Pharmaceuticals (ACAD) — Morgan Stanley lowered its price target from $28.00 to $24.00 and maintained an Equal Weight rating.
Array Digital Infrastructure (AD) — Citigroup lowered its price target from $45.00 to $43.00 and maintained a Buy rating.
Analog Devices (ADI) — Roth Capital initiated coverage with a Buy rating and set a price target of $505.00.
Autodesk (ADSK) — Loop Capital upgraded its rating from Hold to Buy and has a price target of $310.00.
Alliance Entertainment (AENT) — Noble Financial initiated coverage with a Strong Buy rating.
Agilon Health (AGL) — Zacks Research upgraded its rating from Hold to Strong Buy.
Agilon Health (AGL) — Wells Fargo raised its price target from $146.00 to $170.00 and maintained an Overweight rating.
Albany International (AIN) — Truist Financial raised its price target from $61.00 to $71.00 and maintained a Hold rating.
Arthur J. Gallagher & Co. (AJG) — Mizuho raised its price target from $302.00 to $307.00 and maintained an Outperform rating.
Alector (ALEC) — Wells Fargo initiated coverage with an Overweight rating and set a price target of $7.00.
Allegro MicroSystems (ALGM) — Roth Capital initiated coverage with a Buy rating and set a price target of $40.00.
Align Technology (ALGN) — Zacks Research upgraded its rating from Strong Sell to Hold.
Alkami Technology (ALKT) — Stephens initiated coverage with an Equal Weight rating and set a price target of $15.00.
Almonty Industries (ALM) — Stifel lowered its price target from $21.00 to $18.00 and maintained a Buy rating.
Alumis (ALMS) — HC Wainwright lowered its price target from $15.00 to $9.00 and maintained a Buy rating.
Alumis (ALMS) — Wells Fargo lowered its price target from $25.00 to $18.00 and maintained an Overweight rating.
Altimmune (ALT) — Citigroup reiterated a Market Outperform rating.
Altimmune (ALT) — B. Riley Financial reiterated a Buy rating.
Alta Equipment Group (ALTG) — DA Davidson lowered its price target from $8.00 to $6.00 and maintained a Neutral rating.
Applied Materials (AMAT) — Jefferies Financial Group lowered its price target from $770.00 to $580.00 and maintained a Buy rating.
Applied Materials (AMAT) — Needham & Company LLC lowered its price target from $580.00 to $470.00 and maintained a Buy rating.
Applied Materials (AMAT) — Bank of America lowered its price target from $650.00 to $520.00 and maintained a Buy rating.
Applied Materials (AMAT) — Stifel lowered its price target from $650.00 to $600.00 and maintained a Buy rating.
Applied Materials (AMAT) — Sanford C. Bernstein lowered its price target from $700.00 to $600.00 and maintained an Outperform rating.
Applied Materials (AMAT) — Summit Insights downgraded its rating from Buy to Hold.
Applied Materials (AMAT) — TD Securities lowered its price target from $700.00 to $500.00 and maintained a Buy rating.
Applied Materials (AMAT) — RBC reiterated an Outperform rating with a price target of $600.00.
Applied Materials (AMAT) — Wells Fargo lowered its price target from $610.00 to $500.00 and maintained an Overweight rating.
Applied Materials (AMAT) — KeyCorp reiterated an Overweight rating.
Applied Materials (AMAT) — UBS Group lowered its price target from $695.00 to $640.00 and maintained a Buy rating.
Applied Materials (AMAT) — Mizuho lowered its price target from $590.00 to $510.00 and maintained an Outperform rating.
Applied Materials (AMAT) — JPMorgan lowered its price target from $660.00 to $500.00 and maintained an Overweight rating.
AMETEK (AME) — Truist Financial reiterated a Buy rating with a price target of $316.00 ? $329.00.
Affiliated Managers Group (AMG) — Zacks Research upgraded its rating from Hold to Strong Buy.
Andersen Group (ANDG) — Robert W. Baird raised its price target from $64.00 to $71.00 and maintained an Outperform rating.
Andersen Group (ANDG) — Wells Fargo raised its price target from $49.00 to $61.00 and maintained an Equal Weight rating.
AON (AON) — Mizuho raised its price target from $363.00 to $373.00 and maintained an Outperform rating.
AON (AON) — Keefe, Bruyette & Woods raised its price target from $342.00 to $376.00 and maintained an Outperform rating.
APA (APA) — Barclays raised its price target from $44.00 to $48.00 and maintained an Equal Weight rating.
Apollo Global Management (APO) — Piper Sandler downgraded its rating from Overweight to Cautious.
Apollo Global Management (APO) — UBS Group reiterated a Buy rating with a price target of $160.00.
Aptiv (APTV) — Daiwa Securities Group downgraded its rating from Outperform to Hold and has a price target of $41.00.
Ardent Health (ARDT) — Bank of America raised its price target from $12.00 to $14.00 and maintained an Underperform rating.
Alexandria Real Estate Equities (ARE) — Bank of America downgraded its rating from Neutral to Underperform and revised its price target from $55.00 to $45.00.
Alexandria Real Estate Equities (ARE) — Jefferies Financial Group downgraded its rating from Hold to Moderate Sell.
argenex (ARGX) — Morgan Stanley lowered its price target from $1,190.00 to $1,130.00 and maintained an Overweight rating.
Arrowhead Pharmaceuticals (ARWR) — RBC reiterated an Outperform rating with a price target of $100.00.
Arrowhead Pharmaceuticals (ARWR) — Stifel lowered its price target from $104.00 to $96.00 and maintained a Buy rating.
Ascendis Pharma A/S (ASND) — HC Wainwright lowered its price target from $344.00 to $335.00 and maintained a Buy rating.
Ascendis Pharma A/S (ASND) — Canaccord Genuity Group raised its price target from $268.00 to $274.00 and maintained a Hold rating.
Ascendis Pharma A/S (ASND) — Cantor Fitzgerald raised its price target from $300.00 to $315.00 and maintained an Overweight rating.
Ascendis Pharma A/S (ASND) — RBC reiterated an Outperform rating with a price target of $290.00.
Ascendis Pharma A/S (ASND) — TD Securities raised its price target from $341.00 to $352.00 and maintained a Buy rating.
Ascendis Pharma A/S (ASND) — UBS Group raised its price target from $269.00 to $315.00 and maintained a Buy rating.
Ascendis Pharma A/S (ASND) — RBC set a price target of $352.00, with no accompanying rating specified.
Ascendis Pharma A/S (ASND) — Raymond James Financial reiterated an Outperform rating.
Ascendis Pharma A/S (ASND) — KeyCorp set a price target of $330.00, with no accompanying rating specified.
Ascendis Pharma A/S (ASND) — Wells Fargo raised its price target from $326.00 to $330.00 and maintained an Overweight rating.
Alphatec (ATEC) — HC Wainwright lowered its price target from $24.00 to $20.00 and maintained a Buy rating.
ATI (ATI) — Citigroup raised its price target from $229.00 to $240.00 and maintained a Buy rating.
ATI (ATI) — BTIG Research raised its price target from $250.00 to $260.00 and maintained a Buy rating.
Aveanna Healthcare (AVAH) — RBC reiterated an Outperform rating.
Broadcom (AVGO) — Rothschild & Co Redburn downgraded its rating from Buy to Neutral and revised its price target from $595.00 to $398.00.
Anteris Technologies Global (AVR) — Barclays lowered its price target from $10.00 to $9.00 and maintained an Equal Weight rating.
Avnet (AVT) — Bank of America lowered its price target from $115.00 to $110.00 and maintained a Neutral rating.
Axsome Therapeutics (AXSM) — Morgan Stanley lowered its price target from $249.00 to $223.00 and maintained an Equal Weight rating.
Brookfield Asset Management (BAM) — Wells Fargo raised its price target from $51.00 to $57.00 and maintained an Overweight rating.
BridgeBio Pharma (BBIO) — Morgan Stanley raised its price target from $88.00 to $91.00 and maintained an Overweight rating.
Bath & Body Works (BBWI) — UBS Group raised its price target from $17.00 to $22.00 and maintained a Neutral rating.
Better Home & Finance (BETR) — Cantor Fitzgerald changed its rating from Hold to Strong Sell.
Bilibili (BILI) — CLSA initiated coverage with a Strong Buy rating.
BJ’s Wholesale Club (BJ) — JPMorgan raised its price target from $100.00 to $113.00 and maintained a Neutral rating.
BJ’s Wholesale Club (BJ) — Wells Fargo raised its price target from $110.00 to $120.00 and maintained an Overweight rating.
BKV (BKV) — Barclays lowered its price target from $36.00 to $33.00 and maintained an Overweight rating.
Belite Bio (BLTE) — Leerink Partners raised its price target from $185.00 to $215.00 and maintained an Outperform rating.
BitMine Immersion Technologies (BMNR) — B. Riley Financial lowered its price target from $34.00 to $27.00 and maintained a Buy rating.
BioMarin Pharmaceutical (BMRN) — Morgan Stanley lowered its price target from $119.00 to $103.00 and maintained an Overweight rating.
Brookfield (BN) — RBC lowered its price target from $61.00 to $59.00 and maintained an Outperform rating.
Broadstone Net Lease (BNL) — Truist Financial raised its price target from $21.00 to $22.00 and maintained a Buy rating.
Popular (BPOP) — Hovde Group initiated coverage with a Hold rating and set a price target of $171.00.
Brown & Brown (BRO) — Mizuho raised its price target from $81.00 to $84.00 and maintained an Outperform rating.
Boost Run (BRUN) — DA Davidson has a price target of $10.00 and maintained a Buy rating.
BSR Real Estate Investment Trust (BSRT) — RBC lowered its price target from $12.50 to $11.00 and maintained a Sector Perform rating.
BSR Real Estate Investment Trust (BSRT) — Desjardins lowered its price target from $12.50 to $11.50 and maintained a Buy rating.
Bit Digital (BTBT) — Zacks Research upgraded its rating from Hold to Strong Buy.
Peabody Energy (BTU) — UBS Group initiated coverage with a Strong Buy rating.
Burlington Stores (BURL) — Wells Fargo lowered its price target from $370.00 to $330.00 and maintained an Overweight rating.
Burlington Stores (BURL) — Gordon Haskett downgraded its rating from Hold to Reduce and has a price target of $240.00.
Broadwind Energy (BWEN) — Roth Capital lowered its price target from $6.50 to $5.00 and maintained a Buy rating.
BXP (BXP) — UBS Group lowered its price target from $70.00 to $66.00 and maintained a Neutral rating.
KANZHUN (BZ) — Barclays lowered its price target from $20.00 to $17.00 and maintained an Overweight rating.
KANZHUN (BZ) — 86Research upgraded its rating from Hold to Buy and has a price target of $17.00.
Candel Therapeutics (CADL) — HC Wainwright lowered its price target from $23.00 to $18.00 and maintained a Buy rating.
Candel Therapeutics (CADL) — Stifel lowered its price target from $22.00 to $19.00 and maintained a Buy rating.
Candel Therapeutics (CADL) — Canaccord Genuity Group lowered its price target from $25.00 to $13.00 and maintained a Buy rating.
CAE (CAE) — Zacks Research upgraded its rating from Hold to Strong Buy.
Capricor Therapeutics (CAPR) — Roth Capital reiterated a Neutral rating with a price target of $7.00 ? $10.50.
Crescent Biopharma (CBIO) — HC Wainwright raised its price target from $36.00 to $40.00 and maintained a Buy rating.
Crescent Biopharma (CBIO) — Piper Sandler lowered its price target from $35.00 to $32.00 and maintained an Overweight rating.
Cerebras Systems (CBRS) — UBS Group lowered its price target from $250.00 to $155.00 and maintained a Buy rating.
Cerebras Systems (CBRS) — Needham & Company LLC lowered its price target from $300.00 to $200.00 and maintained a Buy rating.
Cerebras Systems (CBRS) — Mizuho lowered its price target from $300.00 to $240.00 and maintained an Outperform rating.
Cerebras Systems (CBRS) — Wedbush set a price target of $205.00, with no accompanying rating specified.
Cardinal Infrastructure Group (CDNL) — Truist Financial lowered its price target from $30.00 to $10.00 and maintained a Buy rating.
Codere Online Luxembourg (CDRO) — Noble Financial initiated coverage with a Strong Buy rating.
Central Puerto (CEPU) — Zacks Research upgraded its rating from Hold to Strong Buy.
CF Industries (CF) — Sanford C. Bernstein reiterated an Outperform rating.
Cigna Group (CI) — Wells Fargo raised its price target from $307.00 to $325.00 and maintained an Equal Weight rating.
Chimera Investment (CIM) — RBC lowered its price target from $13.00 to $7.00 and maintained a Sector Perform rating.
Cellebrite DI (CLBT) — JPMorgan lowered its price target from $16.00 to $15.00 and maintained an Overweight rating.
Commercial Metals (CMC) — Barclays raised its price target from $72.00 to $77.00 and maintained an Equal Weight rating.
CNX Resources (CNX) — Barclays raised its price target from $35.00 to $36.00 and maintained an Underweight rating.
Americold Realty Trust (COLD) — Piper Sandler upgraded its rating from Neutral to Overweight and revised its price target from $15.00 to $19.00.
Concentra Group Holdings Parent (CON) — Wells Fargo raised its price target from $40.00 to $48.00 and maintained an Overweight rating.
ConocoPhillips (COP) — Barclays raised its price target from $150.00 to $165.00 and maintained an Overweight rating.
California Resources (CRC) — Barclays lowered its price target from $74.00 to $68.00 and maintained an Overweight rating.
CorMedix (CRMD) — Oppenheimer reiterated an Outperform rating with a price target of $15.00 ? $13.00.
Cisco Systems (CSCO) — Citigroup lowered its price target from $139.00 to $120.00 and maintained a Buy rating.
Cisco Systems (CSCO) — Barclays lowered its price target from $123.00 to $109.00 and maintained an Equal Weight rating.
Cisco Systems (CSCO) — Truist Financial lowered its price target from $140.00 to $127.00 and maintained a Buy rating.
Cisco Systems (CSCO) — Wells Fargo lowered its price target from $150.00 to $130.00 and maintained an Overweight rating.
Cisco Systems (CSCO) — Piper Sandler reiterated a Neutral rating with a price target of $125.00 ? $112.00.
Cisco Systems (CSCO) — Rosenblatt Securities lowered its price target from $165.00 to $140.00 and maintained a Buy rating.
Canadian Solar (CSIQ) — Zacks Research upgraded its rating from Strong Sell to Hold.
Cognizant Technology Solutions (CTSH) — Deutsche Bank downgraded its rating from Buy to Hold and revised its price target from $75.00 to $66.00.
Corteva (CTVA) — RBC lowered its price target from $17.00 to $11.00 and maintained an Outperform rating.
Corteva (CTVA) — UBS Group lowered its price target from $15.00 to $10.00 and maintained a Neutral rating.
Corteva (CTVA) — Oppenheimer downgraded its rating from Outperform to Market Perform.
Corteva (CTVA) — Citigroup lowered its price target from $13.65 to $10.30 and maintained a Neutral rating.
Corteva (CTVA) — JPMorgan lowered its price target from $19.00 to $16.00 and maintained an Overweight rating.
CVRx (CVRX) — Cantor Fitzgerald has a price target of $2.00 and maintained an Overweight rating.
CVS Health (CVS) — Sanford C. Bernstein reiterated an Outperform rating.
CVS Health (CVS) — Piper Sandler set a price target of $106.00, with no accompanying rating specified.
Chevron (CVX) — Barclays raised its price target from $244.00 to $248.00 and maintained an Equal Weight rating.
Clearway Energy (CWEN) — Truist Financial raised its price target from $40.00 to $42.00 and maintained a Buy rating.
DoorDash (DASH) — Rosenblatt Securities lowered its price target from $225.00 to $210.00 and maintained a Buy rating.
Dave (DAVE) — Freedom Capital upgraded its rating from Hold to Strong Buy.
Dave (DAVE) — Freedom Broker upgraded its rating from Hold to Buy and has a price target of $350.00.
Diversified Energy (DEC) — Zacks Research downgraded its rating from Strong Buy to Hold.
Journey Medical (DERM) — B. Riley Financial reiterated a Buy rating with a price target of $15.00 ? $13.00.
Dream Finders Homes (DFH) — Zelman & Associates downgraded its rating from Outperform to Neutral.
Delek US (DK) — Mizuho lowered its price target from $83.00 to $80.00 and maintained a Neutral rating.
DICK’S Sporting Goods (DKS) — Wells Fargo raised its price target from $185.00 to $195.00 and maintained an Overweight rating.
Dolby Laboratories (DLB) — Zacks Research upgraded its rating from Strong Sell to Hold.
Digimarc (DMRC) — Needham & Company LLC reiterated a Buy rating.
Denali Therapeutics (DNLI) — Wells Fargo initiated coverage with an Overweight rating and set a price target of $35.00.
Denali Therapeutics (DNLI) — Morgan Stanley lowered its price target from $42.00 to $37.00 and maintained an Overweight rating.
Domino’s Pizza (DPZ) — Robert W. Baird upgraded its rating from Neutral to Outperform and revised its price target from $320.00 to $400.00.
Domino’s Pizza (DPZ) — BMO Capital Markets reiterated an Outperform rating.
DarioHealth (DRIO) — Stifel has a price target of $5.00 and maintained a Buy rating.
DT Midstream (DTM) — The Goldman Sachs Group upgraded its rating from Sell to Neutral and revised its price target from $121.00 to $127.00.
Devon Energy (DVN) — Barclays raised its price target from $57.00 to $59.00 and maintained an Overweight rating.
Devon Energy (DVN) — Citigroup lowered its price target from $67.00 to $60.00 and maintained a Buy rating.
Ecolab (ECL) — Wells Fargo upgraded its rating from Equal Weight to Overweight and revised its price target from $315.00 to $380.00.
Okeanis Eco Tankers (ECO) — B. Riley Financial raised its price target from $100.00 to $120.00 and maintained a Buy rating.
Okeanis Eco Tankers (ECO) — Zacks Research upgraded its rating from Hold to Strong Buy.
Eagle Financial Services (EFSI) — Freedom Broker raised its price target from $43.00 to $46.20 and maintained a Hold rating.
eHealth (EHTH) — Zacks Research downgraded its rating from Sell (E) to Sell (E+).
enGene (ENGN) — Leerink Partners upgraded its rating from Market Perform to Outperform and has a price target of $5.00.
Enlight Renewable Energy (ENLT) — Truist Financial lowered its price target from $104.00 to $102.00 and maintained a Buy rating.
Enersys (ENS) — Oppenheimer lowered its price target from $250.00 to $210.00 and maintained an Outperform rating.
Enovix (ENVX) — Craig Hallum downgraded its rating from Buy to Hold and has a price target of $2.00.
Enovix (ENVX) — B. Riley Financial downgraded its rating from Buy to Neutral and revised its price target from $9.00 to $2.00.
Enovix (ENVX) — Oppenheimer downgraded its rating from Outperform to Market Perform.
EOG Resources (EOG) — Barclays raised its price target from $155.00 to $168.00 and maintained an Equal Weight rating.
Edgewell Personal Care (EPC) — Wells Fargo raised its price target from $30.00 to $32.00 and maintained an Overweight rating.
EPR Properties (EPR) — Citigroup reiterated a Market Outperform rating.
EPR Properties (EPR) — Citizens Jmp set a price target of $70.00, with no accompanying rating specified.
Equillium (EQ) — Raymond James Financial reiterated a Strong Buy rating.
Equillium (EQ) — Jefferies Financial Group set a price target of $4.00, with a Buy rating.
EquipmentShare.com (EQPT) — Citigroup raised its price target from $23.00 to $22.00 and maintained an Overweight rating.
enCore Energy (EU) — HC Wainwright has a price target of $1.50 and maintained a Buy rating.
enCore Energy (EU) — Canaccord Genuity Group downgraded its rating from Buy to Moderate Buy and has a price target of C$1.50.
Evommune (EVMN) — Needham & Company LLC lowered its price target from $28.00 to $25.00 and maintained a Buy rating.
Exelixis (EXEL) — Morgan Stanley lowered its price target from $60.00 to $57.00 and maintained an Equal Weight rating.
National Vision (EYE) — UBS Group lowered its price target from $34.00 to $31.00 and maintained a Buy rating.
National Vision (EYE) — Barclays lowered its price target from $27.00 to $24.00 and maintained an Overweight rating.
EZCORP (EZPW) — Piper Sandler set a price target of $39.00, with no accompanying rating specified.
EZCORP (EZPW) — Canaccord Genuity Group lowered its price target from $45.00 to $44.00 and maintained a Buy rating.
EZCORP (EZPW) — Roth Capital reiterated a Buy rating with a price target of $40.00.
First American Financial (FAF) — Zacks Research downgraded its rating from Hold to Strong Sell.
Diamondback Energy (FANG) — Barclays raised its price target from $221.00 to $223.00 and maintained an Overweight rating.
Figure Technology Solutions (FIGR) — Needham & Company LLC lowered its price target from $55.00 to $50.00 and maintained a Buy rating.
Flutter Entertainment (FLUT) — Zacks Research upgraded its rating from Strong Sell to Hold.
Firefly Aerospace (FLY) — Jefferies Financial Group lowered its price target from $35.00 to $30.00 and maintained a Buy rating.
Floor & Decor (FND) — Evercore downgraded its rating from In-Line to Underperform and revised its price target from $55.00 to $45.00.
FOX (FOXA) — Morgan Stanley initiated coverage with an Overweight rating and set a price target of $90.00.
Forgent Power Solutions (FPS) — Sanford C. Bernstein lowered its price target from $48.00 to $33.00 and maintained an Outperform rating.
Forgent Power Solutions (FPS) — Robert W. Baird lowered its price target from $55.00 to $38.00 and maintained an Outperform rating.
Forgent Power Solutions (FPS) — TD Securities lowered its price target from $76.00 to $55.00 and maintained a Buy rating.
Forgent Power Solutions (FPS) — KeyCorp lowered its price target from $60.00 to $46.00 and maintained an Overweight rating.
Forgent Power Solutions (FPS) — Oppenheimer lowered its price target from $60.00 to $40.00 and maintained an Outperform rating.
fuboTV (FUBO) — B. Riley Financial lowered its price target from $18.00 to $16.00 and maintained a Buy rating.
First Watch Restaurant Group (FWRG) — Jefferies Financial Group set a price target of $20.00, with a Buy rating.
GAP (GAP) — Wells Fargo lowered its price target from $23.00 to $22.00 and maintained an Equal Weight rating.
Grid Dynamics (GDYN) — Zacks Research upgraded its rating from Hold to Strong Buy.
GH Research (GHRS) — Stifel set a price target of $38.00, with no accompanying rating specified.
Gilat Satellite Networks (GILT) — Freedom Broker lowered its price target from $18.40 to $13.30 and maintained a Buy rating.
Global-e Online (GLBE) — Piper Sandler reiterated an Overweight rating with a price target of $52.00.
Genmab A/S (GMAB) — Morgan Stanley lowered its price target from $57.00 to $56.00 and maintained an Equal Weight rating.
Global Payments (GPN) — Raymond James Financial reiterated a Market Perform rating.
Green Brick Partners (GRBK) — BTIG Research reiterated a Neutral rating.
Granite Ridge Resources (GRNT) — Freedom Broker downgraded its rating from Buy to Hold and has a price target of $7.00.
Haemonetics (HAE) — Jefferies Financial Group initiated coverage with an Overweight rating and revised its price target from $22.00 to $24.00.
Horace Mann Educators (HMN) — Zacks Research upgraded its rating from Hold to Strong Buy.
Robinhood Markets (HOOD) — The Goldman Sachs Group lowered its price target from $128.00 to $115.00 and maintained a Buy rating.
HireQuest (HQI) — DA Davidson set a price target of $22.00, with no accompanying rating specified.
Harmony Biosciences (HRMY) — Zacks Research downgraded its rating from Strong Buy to Hold.
Heartflow (HTFL) — Wells Fargo raised its price target from $39.00 to $70.00 and maintained an Overweight rating.
Heartflow (HTFL) — Stifel raised its price target from $45.00 to $70.00 and maintained a Buy rating.
Heartflow (HTFL) — Canaccord Genuity Group raised its price target from $56.00 to $69.00 and maintained a Buy rating.
Heartflow (HTFL) — Robert W. Baird raised its price target from $56.00 to $68.00 and maintained an Outperform rating.
HubSpot (HUBS) — Needham & Company LLC reiterated a Buy rating.
HubSpot (HUBS) — UBS Group set a price target of $190.00, with a Underperform rating.
Hancock Whitney (HWC) — Piper Sandler downgraded its rating from Overweight to Neutral and revised its price target from $88.00 to $71.50.
Hancock Whitney (HWC) — Stephens downgraded its rating from Strong Buy to Hold.
Hancock Whitney (HWC) — StoneX set a price target of $81.00, with no accompanying rating specified.
Hancock Whitney (HWC) — DA Davidson lowered its price target from $86.00 to $80.00 and maintained a Buy rating.
Installed Building Products (IBP) — Deutsche Bank upgraded its rating from Hold to Buy and revised its price target from $212.00 to $260.00.
i3 Verticals (IIIV) — Stephens initiated coverage with an Equal Weight rating and set a price target of $23.00.
ImageneBio (IMA) — HC Wainwright initiated coverage with a Strong Buy rating.
Immunocore (IMCR) — Morgan Stanley lowered its price target from $43.00 to $42.00 and maintained an Equal Weight rating.
Innio (INIO) — Piper Sandler initiated coverage with an Overweight rating and set a price target of $21.00.
INmune Bio (INMB) — Freedom Broker lowered its price target from $4.00 to $2.50 and maintained a Buy rating.
Jazz Pharmaceuticals (JAZZ) — Morgan Stanley raised its price target from $319.00 to $324.00 and maintained an Overweight rating.
Jefferson Capital (JCAP) — Jefferies Financial Group reiterated a Buy rating.
Keurig Dr Pepper (KDP) — Jefferies Financial Group reiterated a Hold rating.
Korn/Ferry International (KFY) — Stephens initiated coverage with an Overweight rating and set a price target of $94.00.
Kodiak Gas Services (KGS) — Wells Fargo lowered its price target from $93.00 to $66.00 and maintained an Overweight rating.
KinderCare Learning Companies (KLC) — The Goldman Sachs Group lowered its price target from $3.90 to $3.40 and maintained a Neutral rating.
Coca-Cola (KO) — Bank of America reiterated a Buy rating.
Kodiak Sciences (KOD) — UBS Group raised its price target from $120.00 to $150.00 and maintained a Buy rating.
Kite Realty Group Trust (KRG) — National Bank Financial set a price target of $28.00, with no accompanying rating specified.
Kite Realty Group Trust (KRG) — Bank of America downgraded its rating from Buy to Neutral and revised its price target from $31.00 to $28.00.
Cyclerion Therapeutics (KRSA) — Wells Fargo initiated coverage with an Overweight rating and set a price target of $44.00.
Lithium Americas (LAC) — Canaccord Genuity Group downgraded its rating from Moderate Buy to Hold.
Lithium Americas (LAC) — JPMorgan lowered its price target from $6.00 to $5.00 and maintained an Overweight rating.
Legend Biotech (LEGN) — Evercore downgraded its rating from Outperform to In-Line and has a price target of $20.00.
Levi Strauss & Co. (LEVI) — UBS Group reiterated a Buy rating.
LifeMD (LFMD) — Lake Street Capital lowered its price target from $5.00 to $3.00 and maintained a Buy rating.
LifeMD (LFMD) — Mizuho lowered its price target from $7.00 to $6.00 and maintained an Outperform rating.
Liftoff Mobile (LFTO) — Wells Fargo raised its price target from $21.00 to $27.00 and maintained an Overweight rating.
Liftoff Mobile (LFTO) — Piper Sandler raised its price target from $19.00 to $24.00 and maintained a Neutral rating.
Liftoff Mobile (LFTO) — RBC raised its price target from $35.00 to $38.00 and maintained an Outperform rating.
Liftoff Mobile (LFTO) — Barclays lowered its price target from $34.00 to $30.00 and maintained an Overweight rating.
Liftoff Mobile (LFTO) — Freedom Broker upgraded its rating from Hold to Buy and has a price target of $27.00.
Liftoff Mobile (LFTO) — Freedom Capital upgraded its rating from Hold to Buy and has a price target of $27.00.
Liftoff Mobile (LFTO) — BTIG Research raised its price target from $27.00 to $31.00 and maintained a Buy rating.
Lifevantage (LFVN) — Freedom Broker lowered its price target from $9.00 to $8.00 and maintained a Buy rating.
Lifevantage (LFVN) — UBS Group set a price target of $8.00, with no accompanying rating specified.
LGN (LGN) — Sanford C. Bernstein reiterated an Outperform rating.
LGN (LGN) — BTIG Research lowered its price target from $100.00 to $60.00 and maintained a Buy rating.
Lineage (LINE) — Piper Sandler raised its price target from $36.00 to $37.00 and maintained a Neutral rating.
Lakefront Biotherapeutics American Depositary Shares (LKFT) — TD Securities initiated coverage with a Strong Buy rating.
Lowe’s Companies (LOW) — Evercore downgraded its rating from Hold to Strong Sell.
Lowe’s Companies (LOW) — Stifel downgraded its rating from Hold to Sell and revised its price target from $195.00 to $190.00.
Liquidia (LQDA) — HC Wainwright initiated coverage with a Buy rating and set a price target of $76.00.
Intuitive Machines (LUNR) — Roth Capital lowered its price target from $30.00 to $20.00 and maintained a Buy rating.
Lyell Immunopharma (LYEL) — HC Wainwright lowered its price target from $45.00 to $39.00 and maintained a Buy rating.
Mobility Global (MBGL) — JPMorgan raised its price target from $21.00 to $25.00 and maintained a Neutral rating.
Mobility Global (MBGL) — RBC raised its price target from $23.00 to $25.00 and maintained a Sector Perform rating.
Mobility Global (MBGL) — Barclays raised its price target from $23.00 to $25.00 and maintained an Equal Weight rating.
Mobility Global (MBGL) — Robert W. Baird raised its price target from $22.00 to $26.00 and maintained a Neutral rating.
Mobility Global (MBGL) — Wells Fargo raised its price target from $23.00 to $29.00 and maintained an Overweight rating.
Mondelez International (MDLZ) — BTIG Research reiterated a Buy rating.
MiniMed Group (MMED) — Barclays lowered its price target from $22.00 to $20.00 and maintained an Equal Weight rating.
monday.com (MNDY) — Zacks Research upgraded its rating from Hold to Strong Buy.
Marathon Petroleum (MPC) — Zacks Research downgraded its rating from Strong Buy to Hold.
Marathon Petroleum (MPC) — Mizuho lowered its price target from $457.00 to $440.00 and maintained a Neutral rating.
MP Materials (MP) — Zacks Research upgraded its rating from Strong Sell to Hold.
Marker Therapeutics (MRKR) — Zacks Research downgraded its rating from Strong Buy to Hold.
Marsh & McLennan Companies (MRSH) — Mizuho raised its price target from $200.00 to $218.00 and maintained a Neutral rating.
Murphy Oil (MUR) — Barclays raised its price target from $34.00 to $35.00 and maintained an Underweight rating.
SOLV Energy (MWH) — JPMorgan raised its price target from $34.00 to $36.00 and maintained an Overweight rating.
Nebius Group (NBIS) — DA Davidson lowered its price target from $250.00 to $125.00 and maintained a Neutral rating.
Nebius Group (NBIS) — Robert W. Baird lowered its price target from $340.00 to $200.00 and maintained an Outperform rating.
Nebius Group (NBIS) — Rosenblatt Securities reiterated a Buy rating with a price target of $304.00.
Nebius Group (NBIS) — Truist Financial reiterated a Buy rating with a price target of $355.00 ? $245.00.
Neurocrine Biosciences (NBIX) — Morgan Stanley raised its price target from $185.00 to $191.00 and maintained an Equal Weight rating.
Nexxen International (NEXN) — RBC raised its price target from $13.00 to $14.00 and maintained an Outperform rating.
National Health Investors (NHI) — Bank of America downgraded its rating from Buy to Underperform and revised its price target from $86.00 to $67.00.
NIQ Global Intelligence (NIQ) — Needham & Company LLC raised its price target from $21.00 to $24.00 and maintained a Buy rating.
NIQ Global Intelligence (NIQ) — Barclays raised its price target from $24.00 to $25.00 and maintained an Overweight rating.
NIQ Global Intelligence (NIQ) — RBC raised its price target from $17.00 to $23.00 and maintained an Outperform rating.
NIQ Global Intelligence (NIQ) — Wells Fargo raised its price target from $16.50 to $22.00 and maintained an Overweight rating.
NIQ Global Intelligence (NIQ) — Bank of America set a price target of $23.00, with a Buy rating.
NIKE (NKE) — Piper Sandler reiterated a Neutral rating.
Newsmax (NMAX) — Noble Financial initiated coverage with a Strong Buy rating.
Newsmax (NMAX) — Freedom Capital upgraded its rating from Hold to Buy and has a price target of $10.00.
Newsmax (NMAX) — Freedom Broker upgraded its rating from Hold to Buy and has a price target of $10.00.
Nouveau Monde Graphite (NMG) — Freedom Broker upgraded its rating from Hold to Buy and revised its price target from $1.48 to $1.64.
NMI (NMIH) — BTIG Research lowered its price target from $54.00 to $52.00 and maintained a Buy rating.
NeuroPace (NPCE) — Cantor Fitzgerald lowered its price target from $21.00 to $12.00 and maintained an Overweight rating.
NeuroPace (NPCE) — KeyCorp lowered its price target from $18.00 to $14.00 and maintained an Overweight rating.
NeuroPace (NPCE) — Wells Fargo downgraded its rating from Overweight to Equal Weight and revised its price target from $19.00 to $9.00.
NeuroPace (NPCE) — JPMorgan downgraded its rating from Overweight to Neutral and revised its price target from $20.00 to $9.00.
NeuroPace (NPCE) — Leerink Partners downgraded its rating from Outperform to Market Perform and has a price target of $7.00.
Neptune Insurance (NP) — Mizuho lowered its price target from $33.00 to $31.00 and maintained a Neutral rating.
NerdWallet (NRDS) — Oppenheimer downgraded its rating from Outperform to Market Perform.
Intellia Therapeutics (NTLA) — Citigroup reiterated a Market Outperform rating.
Intellia Therapeutics (NTLA) — Citizens Jmp set a price target of $30.00, with no accompanying rating specified.
Netskope (NTSK) — Morgan Stanley downgraded its rating from Overweight to Equal Weight and revised its price target from $16.00 to $24.00.
NetSol Technologies (NTWK) — Noble Financial initiated coverage with a Strong Buy rating.
New Era Energy & Digital (NUAI) — Roth Capital raised its price target from $7.00 to $17.00 and maintained a Buy rating.
NU (NU) — Needham & Company LLC reiterated a Buy rating with a price target of $19.00.
NVIDIA (NVDA) — Barclays lowered its price target from $275.00 to $210.00 and maintained an Overweight rating.
NVIDIA (NVDA) — HSBC downgraded its rating from Buy to Hold and has a price target of $170.00.
NVIDIA (NVDA) — GF Securities downgraded its rating from Buy to Hold and has a price target of $188.00.
NVIDIA (NVDA) — Rosenblatt Securities lowered its price target from $390.00 to $300.00 and maintained a Buy rating.
NVIDIA (NVDA) — Wells Fargo downgraded its rating from Strong Buy to Hold.
Orchestra BioMed (OBIO) — HC Wainwright raised its price target from $10.00 to $12.00 and maintained a Buy rating.
Orchestra BioMed (OBIO) — BTIG Research raised its price target from $10.00 to $12.00 and maintained a Buy rating.
Once Upon A Farm (OFRM) — TD Securities lowered its price target from $13.00 to $10.00 and maintained a Hold rating.
Oklo (OKLO) — Truist Financial lowered its price target from $31.00 to $28.00 and maintained a Hold rating.
Omnicell (OMCL) — BTIG Research reiterated a Neutral rating.
BeOne Medicines (ONC) — Morgan Stanley raised its price target from $465.00 to $476.00 and maintained an Overweight rating.
Ondas (ONDS) — Needham & Company LLC lowered its price target from $19.00 to $14.00 and maintained a Buy rating.
Ondas (ONDS) — Rothschild & Co Redburn set a price target of $14.00, with no accompanying rating specified.
Ondas (ONDS) — Citigroup reiterated a Market Outperform rating.
Ondas (ONDS) — Lake Street Capital lowered its price target from $19.00 to $14.00 and maintained a Buy rating.
OR Royalties (OR) — Raymond James Financial issued a target update without a quoted target, with a Sell (E-) rating.
Ovintiv (OVV) — Citigroup raised its price target from $68.00 to $74.00 and maintained a Buy rating.
Ovintiv (OVV) — Barclays raised its price target from $80.00 to $85.00 and maintained an Overweight rating.
Occidental Petroleum (OXY) — Barclays raised its price target from $71.00 to $73.00 and maintained an Overweight rating.
Proficient Auto Logistics (PAL) — Stifel lowered its price target from $10.00 to $9.00 and maintained a Buy rating.
Proficient Auto Logistics (PAL) — Barrington Research lowered its price target from $12.00 to $9.00 and maintained an Outperform rating.
Palo Alto Networks (PANW) — KeyCorp upgraded its rating from Sector Weight to Overweight and has a price target of $380.00.
PAR Technology (PAR) — Stephens initiated coverage with an Equal Weight rating and set a price target of $25.00.
Par Pacific (PARR) — Mizuho lowered its price target from $91.00 to $80.00 and maintained a Neutral rating.
PepGen (PEPG) — Guggenheim raised its price target from $7.00 to $15.00 and maintained a Buy rating.
PepsiCo (PEP) — Sanford C. Bernstein reiterated an Outperform rating with a price target of $144.00.
Fidelis Insurance (PLGO) — Keefe, Bruyette & Woods raised its price target from $28.00 to $32.00 and maintained an Outperform rating.
Douglas Dynamics (PLOW) — Freedom Broker lowered its price target from $56.00 to $55.00 and maintained a Buy rating.
Plexus (PLXS) — Raymond James Financial reiterated an Outperform rating.
Power Integrations (POWI) — Roth Capital initiated coverage with a Buy rating and set a price target of $52.00.
Perpetua Resources (PPTA) — Zacks Research upgraded its rating from Strong Sell to Hold.
Porch Group (PRCH) — Zacks Research downgraded its rating from Strong Buy to Hold.
Perimeter Solutions (PRM) — Zacks Research downgraded its rating from Hold to Strong Sell.
ProQR Therapeutics (PRQR) — Citigroup reiterated a Market Outperform rating.
ProQR Therapeutics (PRQR) — Raymond James Financial reiterated a Strong Buy rating.
Paysafe (PSFE) — UBS Group lowered its price target from $7.00 to $3.50 and maintained a Sell rating.
Paysafe (PSFE) — RBC lowered its price target from $9.00 to $6.00 and maintained a Sector Perform rating.
Paysafe (PSFE) — BTIG Research downgraded its rating from Buy to Neutral.
Qiagen (QGEN) — UBS Group raised its price target from $48.00 to $50.00 and maintained a Neutral rating.
QuinStreet (QNST) — Stephens changed its rating from Hold (C-) to Hold (C).
QXO (QXO) — DA Davidson lowered its price target from $20.00 to $19.00 and maintained a Buy rating.
QXO (QXO) — KeyCorp lowered its price target from $28.00 to $19.00 and maintained an Overweight rating.
Ralliant (RAL) — Zacks Research upgraded its rating from Hold to Strong Buy.
Roblox (RBLX) — BTIG Research upgraded its rating from Strong Sell to Hold.
Roblox (RBLX) — Citigroup downgraded its rating from Buy to Neutral and has a price target of $55.00.
RingCentral (RNG) — Raymond James Financial set a price target of $8.00, with no accompanying rating specified.
Ross Stores (ROST) — Wells Fargo lowered its price target from $248.00 to $242.00 and maintained an Equal Weight rating.
Repay (RPAY) — Stephens initiated coverage with an Equal Weight rating and set a price target of $5.00.
Range Resources (RRC) — Barclays raised its price target from $42.00 to $67.00 and maintained an Equal Weight rating.
Riskified (RSKD) — The Goldman Sachs Group raised its price target from $7.50 to $9.00 and maintained a Sell rating.
Sunrun (RUN) — Wells Fargo lowered its price target from $17.00 to $14.00 and maintained an Overweight rating.
Revolution Medicines (RVMD) — Morgan Stanley lowered its price target from $272.00 to $247.00 and maintained an Overweight rating.
Ryan Specialty (RYAN) — Mizuho raised its price target from $40.00 to $48.00 and maintained a Neutral rating.
SBC Medical Group (SBC) — BTIG Research raised its price target from $8.00 to $10.00 and maintained a Buy rating.
Sally Beauty (SBH) — TD Securities raised its price target from $19.00 to $22.00 and maintained a Buy rating.
Sally Beauty (SBH) — RBC set a price target of $22.00, with no accompanying rating specified.
Service Corporation International (SCI) — Stephens changed its rating from Sell (E+) to Sell (D-).
Seadrill (SDRL) — Citigroup raised its price target from $54.00 to $55.00 and maintained a Neutral rating.
Serve Robotics (SERV) — Freedom Capital downgraded its rating from Buy to Hold and has a price target of $3.50.
Serve Robotics (SERV) — Freedom Broker downgraded its rating from Buy to Hold and has a price target of $3.50.
SEA (SE) — JPMorgan lowered its price target from $149.00 to $132.00 and maintained an Overweight rating.
Saga Communications (SGA) — Noble Financial initiated coverage with a Hold rating.
Sagimet Biosciences (SGMT) — Wells Fargo set a price target of $27.00, with no accompanying rating specified.
Sagimet Biosciences (SGMT) — Citigroup reiterated a Market Outperform rating.
Sagimet Biosciences (SGMT) — The Goldman Sachs Group reiterated a Sell rating.
Sagimet Biosciences (SGMT) — Canaccord Genuity Group lowered its price target from $56.00 to $50.00 and maintained a Buy rating.
Spyglass Pharma (SGP) — Stifel raised its price target from $42.00 to $44.00 and maintained a Buy rating.
Spyglass Pharma (SGP) — Citigroup raised its price target from $42.00 to $45.00 and maintained a Buy rating.
SiTime (SITM) — Zacks Research upgraded its rating from Hold to Strong Buy.
Snail (SNAL) — Noble Financial changed its rating from Sell (E+) to Sell (D-).
Spectrum Brands (SPB) — Raymond James Financial reiterated a Market Perform rating.
Spectrum Brands (SPB) — Canaccord Genuity Group lowered its price target from $110.00 to $105.00 and maintained a Buy rating.
SpaceX (SPCX) — KeyCorp reiterated a Sector Weight rating.
Spire Global (SPIR) — Canaccord Genuity Group lowered its price target from $22.50 to $21.50 and maintained a Buy rating.
Sound Point Meridian Capital (SPMC) — B. Riley Financial lowered its price target from $10.00 to $6.50 and maintained a Neutral rating.
Standard Nuclear (STDN) — Needham & Company LLC reiterated a Buy rating.
STERIS (STE) — Jefferies Financial Group upgraded its rating from Hold to Buy and revised its price target from $232.00 to $305.00.
STERIS (STE) — Morgan Stanley upgraded its rating from Overweight to Buy.
Sutro Biopharma (STRO) — Barclays raised its price target from $56.00 to $57.00 and maintained an Overweight rating.
STUB (STUB) — TD Securities lowered its price target from $12.00 to $10.00 and maintained a Buy rating.
Telephone and Data Systems (TDS) — Citigroup lowered its price target from $47.00 to $44.00 and maintained a Buy rating.
Tecnoglass (TGLS) — B. Riley Financial raised its price target from $55.00 to $63.00 and maintained a Buy rating.
TIM (TIMB) — Barclays raised its price target from $20.00 to $22.00 and maintained an Equal Weight rating.
TJX Companies (TJX) — Wells Fargo lowered its price target from $140.00 to $135.00 and maintained an Equal Weight rating.
TJX Companies (TJX) — Gordon Haskett downgraded its rating from Accumulate to Hold and has a price target of $130.00.
TMC the metals (TMC) — HC Wainwright lowered its price target from $11.75 to $5.50 and maintained a Buy rating.
Teekay Tankers (TNK) — Zacks Research upgraded its rating from Hold to Strong Buy.
Trustmark (TRMK) — Brean Capital downgraded its rating from Strong Buy to Hold.
Terreno Realty (TRNO) — Piper Sandler reiterated an Overweight rating.
Tractor Supply (TSCO) — Stephens downgraded its rating from Hold to Underperform.
Tractor Supply (TSCO) — Evercore downgraded its rating from Outperform to In-Line and revised its price target from $40.00 to $38.00.
Tesla (TSLA) — Glj Research reiterated a Sell rating.
Tenaris (TS) — Stifel raised its price target from $57.00 to $67.00 and maintained a Buy rating.
Tetra Tech (TTEK) — KeyCorp raised its price target from $41.00 to $42.00 and maintained an Overweight rating.
Twist Bioscience (TWST) — Robert W. Baird lowered its price target from $187.00 to $135.00 and maintained an Outperform rating.
Twist Bioscience (TWST) — TD Securities lowered its price target from $190.00 to $137.00 and maintained a Buy rating.
Twist Bioscience (TWST) — Canaccord Genuity Group lowered its price target from $205.00 to $150.00 and maintained a Buy rating.
Twist Bioscience (TWST) — Leerink Partners lowered its price target from $190.00 to $175.00 and maintained an Outperform rating.
Twist Bioscience (TWST) — RBC set a price target of $137.00, with no accompanying rating specified.
United States Antimony (UAMY) — HC Wainwright lowered its price target from $9.25 to $6.50 and maintained a Buy rating.
Ultra Clean (UCTT) — UBS Group changed its rating from Buy to Positive.
Ultra Clean (UCTT) — Barclays initiated coverage with an Equal Weight rating and set a price target of $65.00.
Ultrapar Participacoes (UGP) — Zacks Research downgraded its rating from Strong Buy to Hold.
Unisys (UIS) — Zacks Research upgraded its rating from Strong Sell to Hold.
Urban Outfitters (URBN) — UBS Group reiterated a Neutral rating.
U.S. Physical Therapy (USPH) — Barrington Research has a price target of $72.00 and maintained an Overweight rating.
Visteon (VC) — RBC raised its price target from $100.00 to $102.00 and maintained an Outperform rating.
Versigent (VGNT) — Zacks Research upgraded its rating from Strong Sell to Hold.
Controladora Vuela Compania de Aviacion (VLRS) — Zacks Research upgraded its rating from Strong Sell to Hold.
Vox Royalty (VOXR) — Roth Capital reiterated a Buy rating with a price target of $8.50 ? $8.25.
VirTra (VTSI) — Roth Capital reiterated a Buy rating with a price target of $7.50.
Vylor (VYLR) — UBS Group lowered its price target from $89.00 to $87.00 and maintained a Buy rating.
NCR Voyix (VYX) — Stephens initiated coverage with an Equal Weight rating and set a price target of $12.00.
Warner Music Group (WMG) — Morgan Stanley raised its price target from $36.00 to $39.00 and maintained an Overweight rating.
Advanced Drainage Systems (WMS) — Jefferies Financial Group initiated coverage with a Strong Buy rating.
Walmart (WMT) — Wells Fargo changed its rating from Sell (E+) to Sell (D-).
Wise Group (WSE) — UBS Group raised its price target from $17.25 to $18.00 and maintained a Buy rating.
Willis Towers Watson Public (WTW) — Mizuho raised its price target from $370.00 to $384.00 and maintained an Outperform rating.
Westwater Resources (WWR) — HC Wainwright lowered its price target from $1.50 to $1.25 and maintained a Buy rating.
Wolverine World Wide (WWW) — UBS Group raised its price target from $31.00 to $33.00 and maintained a Buy rating.
Wolverine World Wide (WWW) — Oppenheimer maintained a Market Perform rating.
Wolverine World Wide (WWW) — Williams Trading set a price target of $21.00, with no accompanying rating specified.
Wolverine World Wide (WWW) — Robert W. Baird raised its price target from $26.00 to $27.00 and maintained an Outperform rating.
Wolverine World Wide (WWW) — Stifel raised its price target from $26.00 to $28.00 and maintained a Buy rating.
Wolverine World Wide (WWW) — KeyCorp raised its price target from $25.00 to $27.00 and maintained an Overweight rating.
X-Energy (XE) — TD Securities lowered its price target from $35.00 to $25.00 and maintained a Buy rating.
Xometry (XMTR) — Rosenblatt Securities raised its price target from $130.00 to $140.00 and maintained a Buy rating.
ExxonMobil (XOM) — Barclays raised its price target from $200.00 to $206.00 and maintained an Overweight rating.
Global Medical REIT (XRN) — Zacks Research downgraded its rating from Hold to Strong Sell.
Block (XYZ) — Freedom Broker raised its price target from $105.00 to $115.00 and maintained a Buy rating.
YETI (YETI) — Citigroup lowered its price target from $53.00 to $50.00 and maintained a Buy rating.
YETI (YETI) — KeyCorp lowered its price target from $57.00 to $49.00 and maintained an Overweight rating.
YETI (YETI) — Canaccord Genuity Group lowered its price target from $46.00 to $42.00 and maintained a Hold rating.
YETI (YETI) — Roth Capital reiterated a Buy rating with a price target of $62.00 ? $52.00.
YETI (YETI) — Stifel lowered its price target from $50.00 to $48.00 and maintained a Buy rating.
YETI (YETI) — Robert W. Baird lowered its price target from $57.00 to $50.00 and maintained an Outperform rating.
YETI (YETI) — Piper Sandler downgraded its rating from Overweight to Neutral and revised its price target from $58.00 to $39.00.
York Space Systems (YSS) — Needham & Company LLC lowered its price target from $18.00 to $10.00 and maintained a Buy rating.
York Space Systems (YSS) — Piper Sandler lowered its price target from $8.00 to $7.00 and maintained a Neutral rating.
York Space Systems (YSS) — Jefferies Financial Group downgraded its rating from Buy to Hold and revised its price target from $15.00 to $6.00.
Yesway (YSWY) — Raymond James Financial reiterated an Outperform rating.
Zeta Global (ZETA) — Freedom Broker changed its rating from Sell (E+) to Sell (D-).
Zevra Therapeutics (ZVRA) — BTIG Research lowered its price target from $24.00 to $21.00 and maintained a Buy rating.
Zevra Therapeutics (ZVRA) — Cantor Fitzgerald lowered its price target from $25.00 to $19.00 and maintained an Overweight rating.
Zymeworks (ZYME) — Citizens Jmp raised its price target from $32.00 to $39.00 and maintained a Market Outperform rating.

STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.






